These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7053067)

  • 1. Increased fluid pinocytosis, induced by action of platelet-derived growth factor on quiescent arterial smooth muscle cells, does not require increased cholesterol biosynthesis.
    Habenicht AJ; Glomset JA; Ross R; Gronwald R
    Biochim Biophys Acta; 1980 Sep; 631(3):495-8. PubMed ID: 7053067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and swiss 3T3 cells stimulated to divide by platelet-derived growth factor.
    Habenicht AJ; Glomset JA; Ross R
    J Biol Chem; 1980 Jun; 255(11):5134-40. PubMed ID: 6768732
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for the inhibition of platelet-derived growth factor induced rat smooth muscle cells DNA synthesis by fenofibric acid at the Go/G1 cell cycle level.
    Pascal M; Sepulchre C; Chazan JB; Majoie B
    Life Sci; 1983 Sep; 33(10):925-33. PubMed ID: 6888156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-binding growth factor type one and platelet-derived growth factor are required for the optimal expression of cell surface low density lipoprotein receptor binding activity in human adult arterial smooth muscle cells.
    Chen JK; Hoshi H; McKeehan WL
    In Vitro Cell Dev Biol; 1988 Mar; 24(3):199-204. PubMed ID: 2450862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediation of pinocytosis in cultured arterial smooth muscle and endothelial cells by platelet-derived growth factor.
    Davies PF; Ross R
    J Cell Biol; 1978 Dec; 79(3):663-71. PubMed ID: 103882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types.
    Nègre-Aminou P; van Vliet AK; van Erck M; van Thiel GC; van Leeuwen RE; Cohen LH
    Biochim Biophys Acta; 1997 Apr; 1345(3):259-68. PubMed ID: 9150246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of lovastatin on mitogen induced calcium influx in human cultured vascular smooth muscle cells.
    Clunn GF; Lymn JS; Schachter M; Hughes AD
    Br J Pharmacol; 1997 Aug; 121(8):1789-95. PubMed ID: 9283719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the Influence of mevalonic acid and its metabolites on the morphology of swiss 3T3 cells.
    Schmidt RA; Glomset JA; Wight TN; Habenicht AJ; Ross R
    J Cell Biol; 1982 Oct; 95(1):144-53. PubMed ID: 7142283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mevastatin can cause G1 arrest and induce apoptosis in pulmonary artery smooth muscle cells through a p27Kip1-independent pathway.
    Fouty BW; Rodman DM
    Circ Res; 2003 Mar; 92(5):501-9. PubMed ID: 12600884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of HMG-CoA reductase inhibition on PDGF- and angiotensin II- mediated signal transduction: suppression of c-Jun and c-Fos in human smooth muscle cells in vitro.
    Kreuzer J; Watson L; Herdegen T; Loebe M; Wende P; Kübler K
    Eur J Med Res; 1999 Apr; 4(4):135-43. PubMed ID: 10205288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in human hepatoma cell line Hep G2. Effects of inhibitors of cholesterol synthesis on enzyme activity.
    Boogaard A; Griffioen M; Cohen LH
    Biochem J; 1987 Jan; 241(2):345-51. PubMed ID: 3036060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Koga T; Shimada Y; Kuroda M; Tsujita Y; Hasegawa K; Yamazaki M
    Biochim Biophys Acta; 1990 Jul; 1045(2):115-20. PubMed ID: 2116173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in the ability of compactin and oxidized cholesterol, both known inhibitors of cholesterol biosynthesis, to suppress in vitro immune responses.
    Humphries GM
    Cancer Res; 1981 Sep; 41(9 Pt 2):3789-91. PubMed ID: 7260948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis.
    Alberts AW
    Cardiology; 1990; 77 Suppl 4():14-21. PubMed ID: 2073667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin modulates the heat shock response and cytotoxicity mediated by oxidized LDL in cultured human endothelial smooth muscle cells.
    Pirillo A; Jacoviello C; Longoni C; Radaelli A; Catapano AL
    Biochem Biophys Res Commun; 1997 Feb; 231(2):437-41. PubMed ID: 9070296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitogens for adult rat aortic vascular smooth muscle cells in serum-free primary culture.
    Grainger DJ; Witchell CM; Weissberg PL; Metcalfe JC
    Cardiovasc Res; 1994 Aug; 28(8):1238-42. PubMed ID: 7954627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered cellular responses to serum mitogens, including platelet-derived growth factor, in cultured smooth muscle cells derived from arteries of patients with moyamoya disease.
    Aoyagi M; Fukai N; Sakamoto H; Shinkai T; Matsushima Y; Yamamoto M; Yamamoto K
    J Cell Physiol; 1991 May; 147(2):191-8. PubMed ID: 2040653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of smooth muscle cell calcium mobilization and aortic ring contraction by lactone vastatins.
    Escobales N; Crespo MJ; Altieri PI; Furilla RA
    J Hypertens; 1996 Jan; 14(1):115-21. PubMed ID: 12013483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of compactin, mevalonate and low-density lipoprotein on 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and low-density-lipoprotein-receptor activity in the human hepatoma cell line Hep G2.
    Cohen LH; Griffioen M; Havekes L; Schouten D; van Hinsbergh V; Kempen HJ
    Biochem J; 1984 Aug; 222(1):35-9. PubMed ID: 6089762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the new HMG-CoA reductase inhibitor cerivastatin (BAY W 6228)on migration, proliferation and cholesterol synthesis in arterial myocytes.
    Corsini A; Arnaboldi L; Raiteri M; Quarato P; Faggiotto A; Paoletti R; Fumagalli R
    Pharmacol Res; 1996 Jan; 33(1):55-61. PubMed ID: 8817647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.